International Biomedical Devices Inc.
Capsulotomy system simplifies and improves cataract surgery
This article was originally published in Start Up
Executive Summary
An automated method to ensure a precise incision of the capsular bag for cataract surgery should soon be commercially available from International Biomedical Devices Inc. The Aperture Continuous Thermal Capsulotomy System (ApertureCTC) uses thermal energy delivered through a microincision to a 360-degree, small, steel ring placed on the anterior capsule to create a perfectly round and smooth incision in mere milliseconds.
You may also be interested in...
Finance Watch: LSP Dementia Fund Closes With €260m For Neurodegenerative Diseases
EQT Life Sciences completed the final close of its inaugural LSP Dementia Fund, far surpassing an initial $100m fundraising goal. Also, Resilience received a $410m commitment from the Department of Defense to fund biomanufacturing and Viking cashed in on Phase I obesity data with a $250m offering.
Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign
Campaign featuring actress Meghann Fahy says "allergy sufferers can relieve their allergy symptoms and be more spontaneous in their romantic pursuits.” Ads launch two months after FDA granted tentative approval for two ANDAs for generic equivalents, indicating approval could come pending resolution of patent litigation.
Keytruda, Opdivo May Be Only Part B Drugs Chosen For Medicare Negotiation In First Applicable Year
In general, more Part D drugs will be eligible than Part B drugs in the early years of the program because Part D drugs have higher levels of spending and so will dominate the list of candidates. A new report sizes up the drugs that would qualify for Medicare Price negotiation in 2026-2028.